Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Orbis Diagnostics has developed a desktop-sized point-of-care diagnostic device that delivers laboratory-quality blood test results from a single fingerstick within approximately 15–30 minutes. The first product panel targets the CDC-recommended triplex of Hepatitis B Virus tests for adult screening. The technology uses proprietary microfluidic disks to automate ELISA assays at the point of care. As of mid–2025, the company’s lead product was at the design verification stage with pilot studies and US clinical trials planned for later in the year. No published clinical trial results yet.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Orbis Diagnostics.